CUFinder

Elizabeth Tullis

Elizabeth Tullis

University of Toronto

H-index: 69

North America-Canada

Contact Elizabeth Tullis

About Elizabeth Tullis

Elizabeth Tullis, With an exceptional h-index of 69 and a recent h-index of 42 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of cystic fibrosis.

His recent articles reflect a diverse array of research interests and contributions to the field:

SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends …

Elexacaftor/tezacaftor/ivacaftor treatment and depression-related events

Sleep breathing disorder frequency, risk factors, and treatment among adults with cystic fibrosis

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

Mo1210 MUCOSAL INFLAMMATION OF THE COLON AND TERMINAL ILEUM IN PEOPLE WITH CYSTIC FIBROSIS IS MILD AND NOT ASSOCIATED WITH ABDOMINAL PAIN OR PRESENCE OF COLONIC POLYPS

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification

Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open …

710 Real-world impact of elexacaftor-tezacaftor-ivacaftor on quality of life of adults with cystic fibrosis

Elizabeth Tullis Information

University

Position

___

Citations(all)

20486

Citations(since 2020)

10641

Cited By

14286

hIndex(all)

69

hIndex(since 2020)

42

i10Index(all)

156

i10Index(since 2020)

116

Email

University Profile Page

Google Scholar

Elizabeth Tullis Skills & Research Interests

cystic fibrosis

Top articles of Elizabeth Tullis

SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends …

Pediatric Pulmonology

2024/4/12

Michael Trotter
Michael Trotter

H-Index: 2

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Elexacaftor/tezacaftor/ivacaftor treatment and depression-related events

2024/2/1

David R Demaso
David R Demaso

H-Index: 30

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Sleep breathing disorder frequency, risk factors, and treatment among adults with cystic fibrosis

Journal of Cystic Fibrosis

2024/1/1

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

The Lancet Respiratory Medicine

2023/6/1

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Nitin Nair
Nitin Nair

H-Index: 2

Krishna Pancham
Krishna Pancham

H-Index: 8

Santiago Reyes
Santiago Reyes

H-Index: 0

Joseph Pilewski
Joseph Pilewski

H-Index: 45

Raksha Jain
Raksha Jain

H-Index: 20

Alexander Kiefer
Alexander Kiefer

H-Index: 4

Barry Plant
Barry Plant

H-Index: 20

Peter Middleton
Peter Middleton

H-Index: 12

John Wilson
John Wilson

H-Index: 17

Mo1210 MUCOSAL INFLAMMATION OF THE COLON AND TERMINAL ILEUM IN PEOPLE WITH CYSTIC FIBROSIS IS MILD AND NOT ASSOCIATED WITH ABDOMINAL PAIN OR PRESENCE OF COLONIC POLYPS

Gastroenterology

2023/5/1

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification

Human Genetics and Genomics Advances

2023/1/12

Angela Chen
Angela Chen

H-Index: 3

Fan Lin
Fan Lin

H-Index: 11

Zhuozhi Wang
Zhuozhi Wang

H-Index: 5

Katherine Keenan
Katherine Keenan

H-Index: 11

Naim Panjwani
Naim Panjwani

H-Index: 7

Cheng Wang
Cheng Wang

H-Index: 0

Michael Parkins
Michael Parkins

H-Index: 29

Daniel Hughes
Daniel Hughes

H-Index: 5

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Lei Sun
Lei Sun

H-Index: 4

Felix Ratjen
Felix Ratjen

H-Index: 54

Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open …

American journal of respiratory and critical care medicine

2023/7/1

Susanna A Mccolley
Susanna A Mccolley

H-Index: 31

Paul Mcnally
Paul Mcnally

H-Index: 19

Felix Ratjen
Felix Ratjen

H-Index: 54

Prema Menon
Prema Menon

H-Index: 2

710 Real-world impact of elexacaftor-tezacaftor-ivacaftor on quality of life of adults with cystic fibrosis

Journal of Cystic Fibrosis

2023/10/1

554 Mucosal inflammation of the colon and terminal ileum in peoplewith cystic fibrosis is mild and not associated with abdominal pain or presence of polyps

Journal of Cystic Fibrosis

2023/10/1

S Grover
S Grover

H-Index: 27

619 Changing demographic characteristics of individuals with cystic fibrosis transitioning from pediatric to adult care

Journal of Cystic Fibrosis

2023/10/1

708 Outcomes after liver transplantation in people with cystic fibrosis: systematic review and meta-analysis

2023/10/1

605 Description of sleep breathing disorder prevalence, risk factors, and treatment in adults with cystic fibrosis

Journal of Cystic Fibrosis

2023/10/1

709 Randomized, double-blind, placebo-controlled trial of oral prednisone as adjunctive treatment in pulmonary exacerbations in cystic fibrosis (PIPE Study)

Journal of Cystic Fibrosis

2023/10/1

Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis

Journal of Cystic Fibrosis

2023/9/1

Felix Ratjen
Felix Ratjen

H-Index: 54

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Nick Daneman
Nick Daneman

H-Index: 32

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass

Frontiers in Pharmacology

2023/7/13

Felix Ratjen
Felix Ratjen

H-Index: 54

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

American journal of respiratory and critical care medicine

2023/7/1

Susanna A Mccolley
Susanna A Mccolley

H-Index: 31

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Felix Ratjen
Felix Ratjen

H-Index: 54

WS05. 03 A phase 3b study of the effects of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on glucose tolerance in people with cystic fibrosis (CF) and abnormal glucose metabolism

Journal of Cystic Fibrosis

2023/6/1

EPS6. 05 A phase 3b study of the effects of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on cough and physical activity in people with cystic fibrosis (CF)

Journal of Cystic Fibrosis

2023/6/1

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week …

The Lancet Respiratory Medicine

2022/3/1

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

Christopher Harris
Christopher Harris

H-Index: 5

Yiyue Lou
Yiyue Lou

H-Index: 9

Michael Lorenz
Michael Lorenz

H-Index: 3

Damian Downey
Damian Downey

H-Index: 13

Timothy Lee
Timothy Lee

H-Index: 26

Robert Gray
Robert Gray

H-Index: 1

Philip J Robinson
Philip J Robinson

H-Index: 20

Frailty predicts outcomes in cystic fibrosis patients listed for lung transplantation

The Journal of Heart and Lung Transplantation

2022/11/1

Angela Koutsokera
Angela Koutsokera

H-Index: 17

Kenneth Rockwood
Kenneth Rockwood

H-Index: 81

John-David Aubert
John-David Aubert

H-Index: 19

Elizabeth Tullis
Elizabeth Tullis

H-Index: 39

See List of Professors in Elizabeth Tullis University(University of Toronto)